| Literature DB >> 29294018 |
Rory D de Vries1, Nella J Nieuwkoop1, Fiona R M van der Klis2, Marion P G Koopmans1, Florian Krammer3, Guus F Rimmelzwaan1.
Abstract
Influenza A virus (IAV) and influenza B virus (IBV) cause substantial morbidity and mortality during annual epidemics. Two distinct lineages of IBV are distinguished, based on variation in hemagglutinin (HA): B/Victoria/2/87-like (B/Vic) and B/Yamagata/16/88-like (B/Yam). Here, we show that, in humans, primary IBV infection with either lineage induces HA-specific antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies. IBV infection induced antibodies specific to the HA head and stalk, but only HA stalk-specific antibodies mediated ADCC efficiently and displayed cross-reactivity with IBV of both lineages. This corresponds to recent findings that 2 points of contact between the effector and target cell (ie, HA and sialic acid, respectively, and the fragment crystallizable [Fc] domain and Fcγ receptor IIIα, respectively) are required for efficient ADCC activity and that antibodies specific for the receptor-binding site located in the head domain of HA therefore fail to mediate ADCC. Potentially, ADCC-mediating antibodies directed to the HA stalk of IBV contribute to cross-protective immunity to IBV of both lineages.Entities:
Keywords: Influenza B virus; antibodies; antibody-dependent cellular cytotoxicity; hemagglutinin; natural killer cells
Mesh:
Substances:
Year: 2017 PMID: 29294018 PMCID: PMC5853962 DOI: 10.1093/infdis/jix546
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226